Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Enfusion ( (ENFN) ).
Enfusion, Inc. has entered into a Merger Agreement with Clearwater Analytics Holdings, which will result in Enfusion becoming a wholly-owned subsidiary of Clearwater. The merger will involve several corporate restructuring steps, and upon completion, Enfusion’s Class A Common Stock will be delisted from the NYSE. The agreement has been unanimously recommended by Enfusion’s board, and significant shareholders have committed to supporting the merger. If finalized, this merger is expected to streamline operations and potentially enhance market positioning for both Enfusion and Clearwater.
More about Enfusion
Enfusion, Inc. operates in the financial technology sector, providing cloud-based investment management software and services. The company primarily serves asset managers, hedge funds, and institutional investors, focusing on optimizing their operational workflows and enhancing investment decision-making processes.
YTD Price Performance: 0.91%
Average Trading Volume: 452,729
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.28B
For an in-depth examination of ENFN stock, go to TipRanks’ Stock Analysis page.
